Variant report

Variant	esv1828689
Chromosome Location	chr21:45151046-45160795
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:410)
CpG islands
(count:61)
Chromatin interactive
region (count:17)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:1)

(count:410 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr21:45158438-45158813	K562	blood:	n/a	n/a
2	ATF3	chr21:45160710-45160988	A549	lung:	n/a	chr21:45160849-45160862
3	BACH1	chr21:45160396-45161112	H1-hESC	embryonic stem cell:	n/a	n/a
4	BCL3	chr21:45159769-45160260	A549	lung:	n/a	chr21:45159789-45159802
5	BCL3	chr21:45160274-45161086	A549	lung:	n/a	chr21:45160409-45160418
6	BHLHE40	chr21:45158311-45158664	K562	blood:	n/a	n/a
7	BHLHE40	chr21:45158061-45158395	HepG2	liver:	n/a	n/a
8	BHLHE40	chr21:45151447-45151650	HepG2	liver:	n/a	n/a
9	BRCA1	chr21:45151441-45151919	HepG2	liver:	n/a	n/a
10	CBX3	chr21:45158262-45158880	K562	blood:	n/a	n/a
11	CBX3	chr21:45159315-45159743	K562	blood:	n/a	n/a
12	CCNT2	chr21:45156306-45156323	K562	blood:	n/a	n/a
13	CEBPB	chr21:45154230-45154505	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr21:45156918-45156923	H1-hESC	embryonic stem cell:	n/a	n/a
15	CEBPB	chr21:45154181-45154486	HepG2	liver:	n/a	n/a
16	CEBPB	chr21:45154303-45154423	K562	blood:	n/a	n/a
17	CEBPB	chr21:45151502-45151769	HepG2	liver:	n/a	n/a
18	CEBPB	chr21:45156743-45157038	HepG2	liver:	n/a	n/a
19	CEBPB	chr21:45157993-45158303	HepG2	liver:	n/a	n/a
20	CEBPB	chr21:45156847-45156939	A549	lung:	n/a	n/a
21	CEBPB	chr21:45154232-45154434	H1-hESC	embryonic stem cell:	n/a	n/a
22	CEBPB	chr21:45154095-45154547	MCF-7	breast:	n/a	n/a
23	CEBPB	chr21:45158312-45158814	K562	blood:	n/a	n/a
24	CEBPB	chr21:45156852-45156935	K562	blood:	n/a	n/a
25	CEBPB	chr21:45154174-45154434	A549	lung:	n/a	n/a
26	CEBPB	chr21:45154180-45154520	IMR90	lung:	n/a	n/a
27	CEBPB	chr21:45152397-45152586	IMR90	lung:	n/a	n/a
28	CEBPB	chr21:45152297-45152700	ECC-1	luminal epithelium:	n/a	n/a
29	CEBPD	chr21:45158300-45158858	K562	blood:	n/a	n/a
30	CEBPD	chr21:45151337-45151673	HepG2	liver:	n/a	n/a
31	CREB1	chr21:45160660-45161034	H1-hESC	embryonic stem cell:	n/a	n/a
32	CREB1	chr21:45160649-45161059	A549	lung:	n/a	n/a
33	CTCF	chr21:45157267-45157316	MCF-7	breast:	n/a	n/a
34	CTCF	chr21:45157300-45157450	Hela-S3	cervix:	n/a	n/a
35	CTCF	chr21:45151920-45152070	RPTEC	kidney:	n/a	n/a
36	CTCF	chr21:45158160-45158310	HepG2	liver:	n/a	n/a
37	CTCF	chr21:45158237-45158340	HepG2	liver:	n/a	n/a
38	CTCF	chr21:45157283-45157331	Hela-S3	cervix:	n/a	n/a
39	CTCF	chr21:45152020-45152170	AG10803	skin:	n/a	n/a
40	CTCF	chr21:45157140-45157290	WERI-Rb-1	eye:	n/a	n/a
41	CTCF	chr21:45158631-45158670	Kidney_OC	kidney:	n/a	n/a
42	CTCF	chr21:45151960-45152110	AoAF	blood vessel:	n/a	n/a
43	CTCF	chr21:45157260-45157410	A549	lung:	n/a	n/a
44	CTCF	chr21:45157180-45157330	RPTEC	kidney:	n/a	n/a
45	CTCF	chr21:45157100-45157250	GM12878	blood:	n/a	n/a
46	CTCF	chr21:45157290-45157306	MCF-7	breast:	n/a	n/a
47	CTCF	chr21:45157340-45157490	HepG2	liver:	n/a	n/a
48	CTCF	chr21:45152080-45152230	HAc	cerebellar:	n/a	n/a
49	CTCF	chr21:45157260-45157410	HepG2	liver:	n/a	n/a
50	CTCF	chr21:45151960-45152110	AG09319	gingival:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr21:45153009-45153059	BJ	skin:	n/a
2	chr21:45153009-45153059	SAEC	small airway:	n/a
3	chr21:45153009-45153059	Hepatocyte	liver:	n/a
4	chr21:45153009-45153059	HRCEpiC	kidney:	n/a
5	chr21:45153009-45153059	HAEpiC	amniotic membrane:	n/a
6	chr21:45153009-45153059	NH-A	brain:	n/a
7	chr21:45153009-45153059	SK-N-SH	brain:	n/a
8	chr21:45153009-45153059	HCPEpiC	choroid plexus:	n/a
9	chr21:45153009-45153059	GM19239	blood:	n/a
10	chr21:45153009-45153059	HL-60	blood:	n/a
11	chr21:45153009-45153059	CMK	blood:	n/a
12	chr21:45153009-45153059	AG04449	skin:	fetal
13	chr21:45153009-45153059	T-47D	breast:	n/a
14	chr21:45153009-45153059	HRPEpiC	eye:	n/a
15	chr21:45153009-45153059	U87	brain:	n/a
16	chr21:45153009-45153059	AG09319	gingival:	n/a
17	chr21:45153009-45153059	MCF-7	breast:	n/a
18	chr21:45153009-45153059	PrEC	prostate:	n/a
19	chr21:45153009-45153059	A549	lung:	n/a
20	chr21:45153009-45153059	HCF	heart:	n/a
21	chr21:45153009-45153059	GM12891	blood:	n/a
22	chr21:45153009-45153059	NHBE	bronchial:	n/a
23	chr21:45153009-45153059	NHDF-neo	bronchial:	n/a
24	chr21:45153009-45153059	LNCaP	prostate:	n/a
25	chr21:45153009-45153059	GM06990	blood:	n/a
26	chr21:45153009-45153059	HEK293	kidney:	embryo
27	chr21:45153009-45153059	SK-N-MC	brain:	n/a
28	chr21:45153009-45153059	HNPCEpiC	eye:	n/a
29	chr21:45153009-45153059	SK-N-SH_RA	brain:	n/a
30	chr21:45153009-45153059	PFSK-1	brain:	n/a
31	chr21:45153009-45153059	HUVEC	blood vessel:	n/a
32	chr21:45153009-45153059	GM12892	blood:	n/a
33	chr21:45153009-45153059	MCF10A-Er-Src	breast:	n/a
34	chr21:45153009-45153059	ProgFib	skin:	n/a
35	chr21:45153009-45153059	H1-hESC	embryonic stem cell:	embryo
36	chr21:45153009-45153059	ECC-1	luminal epithelium:	n/a
37	chr21:45153009-45153059	Hela-S3	cervix:	n/a
38	chr21:45153009-45153059	NT2-D1	testis:	n/a
39	chr21:45153009-45153059	Jurkat	blood:	n/a
40	chr21:45153009-45153059	HEEpiC	esophagus:	n/a
41	chr21:45153009-45153059	HCM	heart:	n/a
42	chr21:45153009-45153059	SKMC	muscle:	n/a
43	chr21:45153009-45153059	PANC-1	pancreas:	n/a
44	chr21:45153009-45153059	AoSMC	blood vessel:	n/a
45	chr21:45153009-45153059	BE2_C	brain:	n/a
46	chr21:45153009-45153059	AG04450	lung:	fetal
47	chr21:45153009-45153059	Caco-2	colon:	n/a
48	chr21:45153009-45153059	HCT-116	colon:	n/a
49	chr21:45153009-45153059	HPAEpiC	pulmonary alveolar:	n/a
50	chr21:45153009-45153059	HRE	kidney:	n/a

(count:17 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr21:45153763..45156767-chr21:45158365..45161211,5	MCF-7	breast:
2	chr21:45156014..45158647-chr21:45159074..45160757,2	K562	blood:
3	chr21:45159250..45162021-chr21:45208113..45211544,3	MCF-7	breast:
4	chr21:45152139..45163298-chr21:45164540..45174522,16	K562	blood:
5	chr21:45150500..45152044-chr21:45185669..45188271,2	MCF-7	breast:
6	chr21:45158615..45161441-chr21:45207897..45210708,2	K562	blood:
7	chr21:45077838..45080620-chr21:45152184..45154376,2	MCF-7	breast:
8	chr21:44935059..44936997-chr21:45153609..45155904,2	MCF-7	breast:
9	chr21:45154001..45156611-chr21:45177637..45180387,2	K562	blood:
10	chr21:45154933..45157513-chr21:45174243..45177077,2	MCF-7	breast:
11	chr21:45156182..45158069-chr21:45230385..45232004,2	K562	blood:
12	chr21:45151886..45156250-chr21:45192617..45197213,5	MCF-7	breast:
13	chr21:45156965..45158670-chr21:45174699..45176799,2	K562	blood:
14	chr21:45154618..45156575-chr21:45170589..45173066,2	K562	blood:
15	chr21:45159502..45161246-chr21:45194764..45196763,2	MCF-7	breast:
16	chr21:45156014..45158637-chr21:45159074..45161792,2	K562	blood:
17	chr21:45156014..45158647-chr21:45159074..45160757,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RRP1B-1	chr21:45152020-45152146	ENSG00000241238.1

No data

(count:1 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	PDXK	hsa-miR-193b-3p	chr21:45157285-45157305

Variant related genes	Relation type
PDXK	TF binding region
PDXK	CpG island
ENSG00000160209	chromatin interactions
ENSG00000160207	chromatin interactions
ENSG00000160214	chromatin interactions
ENSG00000160208	chromatin interactions
ENSG00000160213	chromatin interactions

Extended variants
information (count: 500 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:500 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2838358	chr21:45151046-45151047	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs569998301	chr21:45151083-45151084	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs75090478	chr21:45151100-45151101	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs192934966	chr21:45151116-45151117	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs4819305	chr21:45151117-45151118	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs138143993	chr21:45151125-45151126	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs372609721	chr21:45151128-45151129	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs60765519	chr21:45151134-45151135	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs116820812	chr21:45151148-45151149	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs142727570	chr21:45151174-45151175	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs114408763	chr21:45151203-45151204	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs564409577	chr21:45151208-45151209	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs562153874	chr21:45151249-45151250	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs543675312	chr21:45151278-45151279	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs183094152	chr21:45151284-45151285	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs200098918	chr21:45151292-45151293	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs531100901	chr21:45151302-45151303	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs368562368	chr21:45151303-45151304	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs549314044	chr21:45151329-45151330	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs187773082	chr21:45151335-45151336	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs541785258	chr21:45151361-45151362	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs370132381	chr21:45151387-45151388	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs766242	chr21:45151472-45151473	Weak transcription Enhancers Genic enhancers Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs576518865	chr21:45151538-45151539	Weak transcription Enhancers Genic enhancers Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs551375271	chr21:45151546-45151547	Weak transcription Enhancers Genic enhancers Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs569685246	chr21:45151552-45151553	Weak transcription Enhancers Genic enhancers Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs531111008	chr21:45151559-45151560	Weak transcription Enhancers Genic enhancers Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs367853618	chr21:45151573-45151574	Weak transcription Enhancers Genic enhancers Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs115536122	chr21:45151610-45151611	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs537217688	chr21:45151621-45151622	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs567800366	chr21:45151623-45151624	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs766241	chr21:45151638-45151639	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs116593933	chr21:45151683-45151684	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs565767030	chr21:45151700-45151701	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs372043161	chr21:45151728-45151729	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs539506794	chr21:45151737-45151738	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs191241378	chr21:45151873-45151874	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs9974754	chr21:45151874-45151875	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
39	rs543362024	chr21:45151876-45151877	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs150188491	chr21:45151927-45151928	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs112141217	chr21:45151928-45151929	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs541203174	chr21:45151935-45151936	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs571623569	chr21:45151949-45151950	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs559086469	chr21:45151961-45151962	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs368244859	chr21:45152013-45152014	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs371965644	chr21:45152016-45152017	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs183740817	chr21:45152029-45152030	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
48	rs375297628	chr21:45152039-45152040	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
49	rs138752676	chr21:45152052-45152053	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
50	rs530922209	chr21:45152090-45152091	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	18628472	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Ewing''s sarcoma	21437220	CNVD
Lung adenocarcinoma	17086460	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute myeloid leukemia	21358987	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	23341502	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Prostate cancer	18632612	CNVD
Neuroblastoma	20406844	CNVD
Acute myeloid leukemia	21251322	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	21364760	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Ewing''s sarcoma	18628472	CNVD
Leukemia	18628472	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:718 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:45146000-45163600	Weak transcription	Dnd41	blood
2	chr21:45148800-45153400	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
3	chr21:45149000-45194400	Weak transcription	Primary T helper naive cells from peripheral blood	blood
4	chr21:45149200-45151200	Enhancers	Primary monocytes fromperipheralblood	blood
5	chr21:45149200-45151200	Enhancers	Stomach Mucosa	stomach
6	chr21:45149200-45152600	Strong transcription	Hela-S3	cervix
7	chr21:45149200-45153200	Enhancers	Primary T cells fromperipheralblood	blood
8	chr21:45149400-45151200	Weak transcription	Rectal Mucosa Donor 29	rectum
9	chr21:45149400-45151200	Weak transcription	Small Intestine	intestine
10	chr21:45149400-45151400	Weak transcription	Psoas Muscle	Psoas
11	chr21:45149400-45153000	Weak transcription	Primary T cells from cord blood	blood
12	chr21:45149400-45153200	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
13	chr21:45149400-45153400	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
14	chr21:45149400-45157600	Weak transcription	Aorta	Aorta
15	chr21:45149400-45175400	Weak transcription	Pancreatic Islets	Pancreatic Islet
16	chr21:45149600-45151200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr21:45149600-45151200	Weak transcription	Muscle Satellite Cultured Cells	--
18	chr21:45149600-45151200	Enhancers	Duodenum Mucosa	Duodenum
19	chr21:45149600-45151200	Weak transcription	Esophagus	oesophagus
20	chr21:45149600-45151200	Weak transcription	Pancreas	Pancrea
21	chr21:45149600-45151200	Weak transcription	HSMM	muscle
22	chr21:45149600-45151200	Weak transcription	Osteobl	bone
23	chr21:45149600-45151400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
24	chr21:45149600-45151400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
25	chr21:45149600-45151400	Weak transcription	Brain Substantia Nigra	brain
26	chr21:45149600-45151400	Weak transcription	Gastric	stomach
27	chr21:45149600-45151400	Weak transcription	Left Ventricle	heart
28	chr21:45149600-45151400	Weak transcription	Skeletal Muscle Male	skeletal muscle
29	chr21:45149600-45151400	Weak transcription	Stomach Smooth Muscle	stomach
30	chr21:45149600-45151400	Weak transcription	Spleen	Spleen
31	chr21:45149600-45151600	Weak transcription	Primary B cells from peripheral blood	blood
32	chr21:45149600-45151600	Enhancers	Fetal Intestine Large	intestine
33	chr21:45149600-45151600	Enhancers	HMEC	breast
34	chr21:45149600-45151600	Weak transcription	NHDF-Ad	bronchial
35	chr21:45149600-45151800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
36	chr21:45149600-45151800	Enhancers	Breast Myoepithelial Primary Cells	Breast
37	chr21:45149600-45151800	Enhancers	Cortex derived primary cultured neurospheres	brain
38	chr21:45149600-45151800	Enhancers	Adipose Nuclei	Adipose
39	chr21:45149600-45151800	Genic enhancers	Fetal Intestine Small	intestine
40	chr21:45149600-45151800	Weak transcription	Placenta	Placenta
41	chr21:45149600-45151800	Weak transcription	NH-A	brain
42	chr21:45149600-45152000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr21:45149600-45152600	Genic enhancers	A549	lung
44	chr21:45149600-45153200	Weak transcription	H9 Cell Line	embryonic stem cell
45	chr21:45149600-45153200	Weak transcription	HUES6 Cell Line	embryonic stem cell
46	chr21:45149600-45153200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
47	chr21:45149600-45153200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
48	chr21:45149600-45153200	Enhancers	Primary neutrophils fromperipheralblood	blood
49	chr21:45149600-45153200	Weak transcription	Primary T helper cells PMA-I stimulated	--
50	chr21:45149600-45153200	Weak transcription	Primary T helper cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links